Abstract--We are developing a dual modality system that combines digital x-ray mammography with gamma emission scintigraphy, on an upright mammography gantry in which the breast is held under mild compression by a support structure that is independent of the detectors. The x-ray source and detectors can be rotated around a fixed rotation axis permitting multiple views of the breast with fixed compression. Two such views can be combined as a stereotactic pair to obtain the threedimensional location of breast lesions. Information about the location of the lesion within the breast permits corrections for attenuation and detector spatial resolution, resulting in more accurate estimation of the true lesion-to-background concentration ratio, based on the image lesion-to-background counts ratio. In this paper, we describe the model used to make these corrections, and present the results of phantom experiments designed to test the accuracy of our calculations.
I. INTRODUCTION ccurate preoperative staging of breast cancer is required to plan surgery and postoperative therapy. Scopinaro et al. have suggested that the uptake of technetium-99m sestamibi is correlated with angiogenesis and thus can be a potential marker for breast cancer invasiveness [1] . Other researchers have examined the degree of correlation between sestamibi uptake and the traditional indicators of malignancy such as desmoplasia and mitotic activity [2] . All these studies require quantification of the differential radiotracer uptake between the lesion and the surrounding healthy breast tissue. Since the depth of the lesion plays an important role in determining the contrast of the lesion in the image [3] , it has to be taken into account if accurate uptake values are to be obtained. The attenuation due to the structure overlying the lesion (between the lesion and the camera), and the detector blur, both act to reduce the lesion contrast in the image. We have developed a model where, based on the depth of the lesion we can calculate the extent of the detector blur and the attenuation caused by the overlying breast tissue. These factors, along with the lesion contrast measured in the image, can be used to calculate the absolute radioactivity concentration in the lesion and in the background, thereby providing an improved estimate of the ratio of their concentrations.
We are developing a dual modality system where the x-ray and gamma detectors are mounted on a single upright unit. The breast is held under mild compression and is independent of the detectors. The x-ray source and the x-ray and gamma detectors rotate around a fixed rotation axis. The support is designed such that the breast can be positioned at a known distance with respect to the rotation axis. The mechanical aspects of this system have been described earlier [4] . Hence it is possible to obtain three-dimensional lesion localization with this system.
II. STEREOTACTIC LOCALIZATION
To calculate the position of the lesion in three dimensions from the stereo image pair, the following set of equations were derived. The co-ordinate system used for the derivation is shown in Fig. 1 . We define the origin of the co-ordinate system to be the point on the rotation axis that is intersected by the line between the x-ray focal spot and the center point of the chest wall edge of the x-ray detector. The x-axis is defined to lie along the medial to lateral direction of the patient, with positive x pointing towards the right of the patient. The y-axis is along the rotation axis of the gantry with the positive direction going into the gantry (away from the patient). The z-axis is defined to be along the detector to source direction when the gantry arm is vertical, with positive z going towards the source.
The two x-ray views are obtained with the gantry arm at angles θ 1 and θ 2 with respect to the vertical, which is taken at the θ = 0 position. If (x d1 ,y d1 ,z d1 ) and (x d2 , y d2 ,z d2 ) are the coordinates of the center point of the chest wall edge of the xray detector at angles θ 1 and θ 2 respectively, then 
where c is the distance between the origin and the center point of the chest wall edge of the detector surface. We define (x 1 ,y 1, z 1 ) and (x 2 ,y 2 ,z 2 ) as the co-ordinates of the points on the detector surface upon which the lesion center is projected in the two stereo images, 1 and 2, respectively. To obtain them, we measure the x offset in the images between the lesion center and the center line of the detector and the y offset between the lesion center and the chest wall edge of the detector. If these offsets are denoted (L x1 ,L y1 ) and (L x2 ,L y2 ), then the spatial co-ordinates (x 1 ,y 1, z 1 ) and (x 2 ,y 2 ,z 2 ) are given by 
Since the gantry rotates around the y-axis, the y location of the lesion in any projection is constant, and y 1 = y 2 . If a is the source to detector distance, the source co-ordinates can be written as We can now write the equations of two lines, one of which contains (x s1 ,y s1 ,z s1 ) and (x 1 ,y 1, z 1 ), and one of which contains (x s2 ,y s2 ,z s2 ) and (x 2 ,y 2 ,z 2 ). The intersection of these lines gives the lesion co-ordinates (x 0 ,y 0 ,z 0 ). If for simplicity we choose the magnitude of θ 1 to be equal to the magnitude of θ 2 , the final equations for x 0 , y 0 and z 0 reduce to
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III. THEORY There are two factors that prevent us from predicting the true lesion radioactivity concentration from the image counts. These are i) the attenuation caused by the tissue overlying the lesion and ii) the blur due to the detector point spread function (PSF). If we can quantify these factors, we can take into account their effects on the image, and hence determine the true concentration of the lesion. In addition, for both lesion pixels and background pixels, scatter adds additional counts, and thus reduces the apparent concentration ratio in the image.
The average number of primary counts per pixel (n b ) in the background region of the image can be calculated by the following equation and has been derived earlier [4] .
where ε is the detection efficiency, t is the acquisition time, p is the pixel size, and C b (z) is the activity per unit volume in the background. D is the thickness of the phantom above the pixel, and µ t is the linear attenuation coefficient of breast tissue for 140 keV gamma rays. In the case where the background activity concentration is uniform, this equation can easily be rearranged to calculate the background concentration.
C n t p e b b t D
The average number of counts obtained in a background pixel of the image is the sum of scatter and the primary counts, n b . These scatter counts have to be subtracted from the sum to obtain the primary background counts.
The lesion concentration is given by:
where N L is the total number of detected counts from the lesion, V L is the lesion volume, t is the acquisition time, ε is the gamma camera efficiency, and A is the attenuation of breast tissue overlying the lesion. The amplitude of the signal from the lesion is reduced by the attenuation due to the overlying tissue. Since the depth, b, of the lesion is known, the amount of attenuation can be calculated and can be compensated for as follows
where N L is the total number of detected lesion counts in the presence of attenuation. For the case of the phantom study reported here, the lesion concentration is given by:
where A w and A wall are the attenuations of the water and acrylic wall, respectively, on the camera side of the phantom.
To calculate the reduction in the image counts at the lesion center due to the PSF of the detector, the twodimensional projection of the spherical lesion on the detector is convoluted with the two-dimensional Gaussian PSF of the detector. The width of the Gaussian in both the dimensions is a function of the distance of the source from the detector surface. The projection of the spherical lesion on a perfect detector (that is a detector whose PSF is a delta function) can be expressed as 
where R is the lesion radius.
The detector PSF can be written as
Convolving the above two function, we get the blurred spatial distribution of the detected lesion counts in the image, N L,blur (x,y). Clearly, N L,blur (x,y) is spread over a larger area and has a reduced height relative to the original lesion projection, N L (x,y). The ratio of the peak amplitude of N L,blur (x,y) to that of N L (x,y) is defined as the contrast reduction coefficient (CRC) [3] .
IV. PHANTOM MEASUREMENTS

A. Lesion Localization
A fillable phantom of rectangular cross section was designed to simulate a radioactive compressed breast. A tube was located at the phantom center to which spherical lesions were attached using low attenuation rods of known lengths, oriented at known angles with respect to the phantom surface. A support was designed that allowed the phantom to be mounted with the tube on the rotation axis of the gantry. A bearing allowed the gantry arm to rotate while the phantom was held stationary. This setup enabled us to place the lesions at accurately known x, y and z co-ordinates. Lesions of interior diameter 0.8 and 1.0 cm from Data Spectrum Corp., Chapel Hill, NC were used for this study. The wall thickness of the lesions was only ~ 1 mm and hence the attenuation through the walls could be ignored for the concentration calculation. With the phantom positioned independently of the x-ray detector, images were acquired at several different angles from -90 to +90. The phantom was filled with water and the lesions contained a small amount of gadolinium-DTPA for enhanced x-ray contrast.
B. Concentration Ratio Measurement
For simplicity, acquisition of the gamma images of the phantom was performed using a gamma camera stationary on the benchtop. A schematic of the experimental setup is shown in Fig. 2 . The lesions and background were filled with a solution of technetium-99m with a concentration ratio of 10:1 to simulate hot lesions in a warm background. The absolute concentration in the background was 0.48 µCi/cc and that in the lesion was 4.9 µCi/cc. In order to test our ability to measure concentration ratios over a range of lesion depths, the central tube of the phantom was attached to a Velmex rotation stage, and rotated independently of the fixed phantom housing. At each angle, ϕ, the coordinates x 0 , y 0 , z 0 of the lesion centers were known based on the known rod lengths and angular spacings. Images were acquired every 15 degrees over a range of 360 degrees. A medium resolution collimator (collimator #2) was used for the studies. The physical parameters for this collimator have been described in [5] .
V. DETECTOR CHARACTERIZATION
The 2D gamma camera PSF was obtained by measuring the FWHM of the image of a Co-57 spot marker from Isotope Products, Los Angeles, CA at a variety of distances. The spot marker, which has an active diameter of ~1.5 mm, was imaged at several locations on the detector surface at a given distance from the collimator face. These images were shifted and summed to obtain a source image profile averaged over the camera surface. The profile of the point source, which was assumed to be a uniform disc of diameter 1.5 mm, was deconvoluted from the averaged profile. The result was then fitted with 2D Gaussian function, and the x and y FWHM were obtained. The results obtained, plotted as a function of the source to collimator distance, are shown in Fig. 3 .
VI. DATA ANALYSIS
A. Lesion Localization
An analysis program written in IDL (Interactive Data Language) was used to locate the lesion center in the stereo images. Using (4), (5) and (6) the co-ordinates of the lesion center were calculated. The z value of the lesion was then used to calculate the lesion and background concentration from the image counts.
B. Concentration Ratio Measurement
The number of events in the pixel imaging the lesion center is the sum of lesion counts, and primary and scatter counts from the background volume above and below the lesion. The average number of primary and scatter background counts must be subtracted from the total lesion pixel counts to obtain the lesion counts. To get the number of background counts for each lesion, a profile through the gamma image is obtained which does not contain any lesions, but has approximately the same x co-ordinate as the lesion. From this row, the average number of background counts is obtained.
The scatter contribution to this background pixel count is subtracted to obtain the primary counts in the background. For the phantom used here, the scatter fraction is approximately constant and uniform throughout the region in which the lesions are located. The technique for obtaining the scatter fraction for a box phantom such as that used in these experiments has been described earlier [4] . The scatter fraction for the energy window -7%/+22% was measured to be 0.2. The background concentration is then determined from the primary background counts as described above in (8).
To calculate the lesion concentration, the row of pixels through the lesion that contains the maximum number of counts is first extracted. In order to obtain a good estimate of the pixel value at the peak of the lesion profile in the presence of statistical fluctuations, the following procedure is used. The detector PSF at the known lesion distance is convoluted with the theoretical lesion projection as in (14) and the theoretical CRC is obtained. The measured x and y FWHMs of the detector PSF, shown in Fig. 3 , were used. The known lesion radius was used. The FWHM of the result of the convolution is used to set the width of a 2D Gaussian, which is then fitted to the background subtracted 2D lesion profile. The peak amplitude of the fitted Gaussian is then taken as the measured lesion counts in the pixel at the center of the lesion image. The peak counts are divided by the CRC to compensate for the detector blur. This peak height is then attributed to the maximum of the unblurred lesion projection function, N L (x,y), and the area under it is calculated to obtain the total counts coming from the lesion. These counts are then divided by the attenuation of the overlying water using (10) and finally the concentration is calculated from (11). Table I shows the results obtained for the stereotactic localization using the x-ray imaging component of the dual modality system. These were obtained with stereo views at angles +15 degrees and -15 degrees. Column 2 gives the known location of the lesion center in the x and z dimension and column 3 gives their location as calculated from the stereo views and equations. The last column gives the result obtained after subtracting the calculated values from the measured values in millimeters. 
VII. RESULTS
A. Lesion Localization
B. Concentration Ratio Measurement
Plot 4 shows, for every ϕ, the image contrast obtained using the measured lesion and background pixel counts, without any corrections made for attenuation or resolution degradation (squares). It also shows the concentration ratio calculated using the measured pixel counts after all the above corrections are made. The results presented here were obtained for a lesion of diameter 1.0 cm and the lesion to background ratio of 10:1. 
VIII. DISCUSSION AND CONCLUSIONS
Our results obtained for the stereotactic lesion localization demonstrate accuracy to within 1-2 mm. This is accurate enough to be able to use the information to make corrections for the attenuation and detector blur and to significantly improve our estimate of the true concentration ratio in the tumor and the background, as is demonstrated in Fig. 4 . However, for this phantom study, our calculations used the known lesion radius and volume. In the clinical situation, these parameters are unknown, and must be estimated from the images. Hence, methods need to be developed to extract this information from the high-resolution x-ray image. Similarly, the scatter fraction in the breast is a parameter that must be measured. The scatter fraction is a function of the location in the breast, and increases with decreasing distance to the chest wall [6] . However, position-dependent energy spectra are routinely obtained during a dual modality scan, and can be used to obtain the position dependent scatter fraction.
We can conclude that with appropriate corrections for attenuation, detector blur and scatter, based on measured lesion location, we can more accurately predict radioactivity concentration ratios. Stereotactic x-ray imaging combined with gamma imaging is a potentially powerful and reliable method to quantify radiotracer uptake in breast tumors. 0-7803-7636-6/03/$17.00 ©2003 IEEE.
